Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 943-080-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 24 June-16 July 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study in accordance with international guidelines
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- Test system: Mice, CBA/CaOlaHsd
Rationale: Recognised as the recommended test system.
Source: Harlan Laboratories B.V.
Postbus 6174
5960 AD Horst / The Netherlands
Number of animals for
pre-test: 4 females
Number of animals for
the main study: 16 females
Number of animals per group: 4 females (nulliparous and non-pregnant)
Number of test groups: 3
Number of control (vehicle) groups: 1
Age (beginning of treatment): 1st and 2nd pre-test: 9 - 10 weeks
Main study: 8 - 9 weeks
Body weight: see Appendix 1 and 2
Identification: The animals were distributed into the test groups at random. All animals belonging to the same experimental group were kept in one cage. In the main experiment, the animals were identified by tail tags. In the pre-experiment, animals were identified by cage number.
Acclimation: At least 5 days prior to the start of dosing under test conditions after health examination. Only animals without any visible signs of illness were used for the study.
The animals were kept conventionally. The experiment was conducted under standard laboratory conditions.
Housing: group
Cage Type: Makrolon Type II (pre-test) / III (main study), with wire mesh top
Bedding: granulated soft wood bedding
Feed: 2018C Teklad Global 18% protein rodent diet
(certified), ad libitum
Water: tap water, ad libitum
Environment: temperature 22 + 2°C
(except for several hours, see deviations)
relative humidity approx. 45-65%
(except for several hours, see deviations)
artificial light 6.00 a.m. - 6.00 p.m. - Vehicle:
- other: cotton seed oil
- Concentration:
- A solubility experiment was performed according to the recommendations given by OECD 429. The highest test item concentration, which could be technically used was a 50% solution in cotton seed oil. Warming to approximately 37°C was used to formulate the test item.
To determine the highest non-irritant test concentration that at the same time did not induce signs of systemic toxicity, a pre-test was performed in two animals and stated in raw data and report. Two mice were treated by (epidermal) topical application to the dorsal surface of each ear with test item concentrations of 25 and 50% once daily each on three consecutive days.
At the tested concentrations the animals did not show any signs of systemic toxicity or body weight loss. However both animals showed signs of excessive local skin irritation (erythema score 3, increase in ear swelling ≥25%), for details see Appendix 1.
Therefore, a second pre-test was performed using test item concentrations of 5 and 10%. At these concentrations, the animals showed a very slight to well defined erythema of the ear skin (score: 1-2, for details see Appendix 1), as well as a slight erythema of the scalp. Furthermore, increased spontaneous activity was observed in both animals from day 3 onwards, which was attributed to the irritative properties of the test item. However no excessive local skin irritation as defined by OECD 429 was present in both animals
Thus, the test item in the main study was assayed at 2.5, 5, and 10%. The highest concentration tested was the highest level that could be achieved whilst avoiding systemic toxicity and excessive local skin irritation as confirmed in the pre-experiment. - No. of animals per dose:
- 4
- Details on study design:
- Each test group of mice was treated by (epidermal) topical application to the dorsal surface of each ear with test item concentrations of 2.5, 5, and 10% in cotton seed oil. The application volume, 25 µL/ear/day, was spread over the entire dorsal surface ( 8 mm) of each ear once daily for three consecutive days. A further group of mice (control animals) was treated with an equivalent volume of the relevant vehicle alone (control animals).
Five days after the first topical application (day 6) 250 µL of phosphate-buffered saline containing 19.7 µCi of 3H-methyl thymidine (equivalent to 78.7 µCi/mL 3HTdR) were injected into each test and control mouse via the tail vein.
Approximately five hours after treatment with 3HTdR all mice were euthanised by using CO2, which was, after harvesting of the lymph nodes, followed by cervical dislocation to ensure death.
The draining lymph nodes were rapidly excised and pooled for each experimental group (8 nodes per group). Single cell suspensions (in phosphate buffered saline) of pooled lymph node cells were prepared by gentle mechanical disaggregation through stainless steel gauze (200 µm mesh size). After washing two times with phosphate buffered saline (approx. 10 mL) the lymph node cells were resuspended in 5 % trichloroacetic acid (approx. 3 mL) and incubated at approximately +4 °C for at least 18 hours for precipitation of macromolecules. The precipitates were then resuspended in 5 % trichloroacetic acid (1 mL) and transferred to scintillation vials with 10 mL of scintillation liquid and thoroughly mixed. The level of 3HTdR incorporation was then measured in a -scintillation counter. Similarly, background 3HTdR levels were also measured in two 1 mL aliquots of 5 % trichloroacetic acid. The -scintillation counter expresses 3HTdR incorporation as the number of radioactive disintegrations per minute. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The mean values and standard deviations were calculated in the body weight tables
- Positive control results:
- see field "Any other information on results including tables"
- Parameter:
- SI
- Value:
- 1
- Test group / Remarks:
- 4
- Remarks on result:
- other: see Remark
- Remarks:
- test item concentration: 0%
- Parameter:
- SI
- Value:
- 1.36
- Test group / Remarks:
- 4
- Remarks on result:
- other: see Remark
- Remarks:
- test item concentration 2.5%
- Parameter:
- SI
- Value:
- 0.93
- Test group / Remarks:
- 4
- Remarks on result:
- other:
- Remarks:
- test item concentration: 5%
- Parameter:
- SI
- Value:
- 20.8
- Test group / Remarks:
- 4
- Remarks on result:
- other:
- Remarks:
- test item concentration: 10%
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- A test item is regarded as a sensitiser in the LLNA if the exposure to one or more test concentration resulted in a 3-fold or greater increase in incorporation of 3HTdR compared with concurrent controls, as indicated by the Stimulation Index (S.I.). The estimated concentration of test item required to produce a S.I. of 3 is referred to as the EC3 value.
In this study Stimulation Indices of 1.36, 0.93 and 2.08 were determined with the test item at concentrations of 2.5, 5, and 10% in cotton seed oil. A dose response was not observed.
The EC3 value could not be calculated, since none of the tested concentrations induced a S.I. greater than the threshold value of 3.
The substance was not a skin sensitiser under the test conditions of this study. - Executive summary:
In the study the test item formulated in cotton seed oil was assessed for its possible skin sensitising potential.
For this purpose a local lymph node assay was performed using test item concentrations of 2.5, 5, and 10%. The highest concentration tested was the highest concentration that could be achieved whilst avoiding systemic toxicity and excessive local skin irritation as confirmed by two pre-experiments.
The animals did not show any signs of systemic toxicity during the course of the study and no cases of mortality were observed. On days 1 to 4, the animals treated witha test item concentration of10% showed an erythema of the ear skin (Score 1). The animals treated with a test item concentration of 5% showed an erythema of the ear skin on day 3 only. Furthermore, erythema of the scalp was noted in the animal treated with 5 and 10%, respectively. Animals treated with 2.5% test item concentration did not show any signs of local skin irritation.
In this study Stimulation Indices (S.I.) of 1.36, 0.93 and 2.08 were determined with the test item at concentrations of 2.5, 5, and 10% in cotton seed oil, respectively.
The substance was not a skin sensitiser under the test conditions of this study.
Reference
Results
Calculation and Results of Individual Data
Vehicle: cotton seed oil
Test item concentration % |
Group |
Measurement DPM |
Calculation |
Result |
||
DPM-BGa) |
number of lymph nodes |
DPM per lymph nodeb) |
S.I. |
|||
--- |
BG I |
21 |
--- |
--- |
--- |
--- |
--- |
BG II |
26 |
--- |
--- |
--- |
--- |
0 |
1 |
25830 |
25806.5 |
8 |
3225.8 |
1.00 |
2.5 |
2 |
35079 |
35055.5 |
8 |
4381.9 |
1.36 |
5 |
3 |
24033 |
24009.5 |
8 |
3001.2 |
0.93 |
10 |
4 |
53752 |
53728.5 |
8 |
6716.1 |
2.08 |
1 = Control Group
2-4= Test Group
a) = The mean value was taken from the figures BG I and BG II
b) = Since the lymph nodes of the animals of a dose group were pooled, DPM/node was determined by dividing the measured value by the number of lymph nodes pooled
The EC3 value could not be calculated, since all S.I.´s are below the threshold value of 3.
No deaths occurred during the study period.
No signs of systemic toxicity were observed during the study period.On days 1 to 4, the animals treated witha test item concentration of10% showed an erythema of the ear skin (Score 1). The animals treated with a test item concentration of 5% showed an erythema of the ear skin on day 3 only. An erythema of the scalp (score: 1) was noted in the animals treated with 5 and 10%, respectively, on day 3 only. Animals treated with 2.5% test item concentration did not show any signs of local skin irritation.
The body weight of the animals, recordedprior to the first application and prior to treatment with3HTdR, was within the range commonly recorded for animals of this strain and age.
Results of the GLP Positive Control
Experiment performed in April 2015 (Harlan study number 1690900). Positive control substance: α-Hexylcinnamaldehyde
Vehicle: acetone:olive oil (4+1, v/v)
Test item concentration % |
Group |
Measurement DPM |
Calculation |
Result |
||
DPM-BGa) |
number of lymph nodes |
DPM per lymph nodeb) |
S.I. |
|||
--- |
BG I |
15 |
--- |
--- |
--- |
--- |
--- |
BG II |
11 |
--- |
--- |
--- |
--- |
0 |
1 |
6228 |
6215.0 |
8 |
776.9 |
1.00 |
5 |
2 |
12016 |
12003.0 |
8 |
1500.4 |
1.93 |
10 |
3 |
16484 |
16471.0 |
8 |
2058.9 |
2.65 |
25 |
4 |
58951 |
58938.0 |
8 |
7367.3 |
9.48 |
1 = Control Group
2-4= Test Group
a) = The value was taken from the figure BG
b) = Since the lymph nodes of the animals of a dose group were pooled, DPM/node was determined by dividing the measured value by the number of lymph nodes pooled
Calculation of the EC3 value:
|
Test item concentration % |
S.I. |
Test Group 3 |
10 (a) |
2.65 (b) |
Test Group 4 |
25 (c) |
9.48 (d) |
EC3 = (a-c) [(3-d)/(b-d)] + c = 10.8% (w/v) |
a,b,c,d = Co-ordinates of the two pairs of data lying immediately above and below the S.I. value of 3 on the LLNA dose response plot.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
- Migrated from Short description of key information:
LLNA study in mice, in accordance with OECD TG 437: No adverse effects observed at concentration of 2.5, 5, 10%. Low Stimulating Indexes. Substance is not a sensitiser.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
In one LLNA study in mice, in accordance with OECD TG 437, no adverse effects were observed at concentration of 2.5, 5, 10%. Additionally, stimulation indexes were found very low. Substance is not classified for skin sensitisation according to CLP regulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.